Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial introductions101
Genetic determinants of plasma lipids in Greenlanders96
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease73
Genetic variation in apolipoprotein A-V in hypertriglyceridemia58
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism39
Polygenic risk scores in familial hypercholesterolemia. Do they have a role?39
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review33
Alveolar macrophages: guardians of the alveolar lipid galaxy25
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?23
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases22
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1922
Oxidized LDL receptors: a recent update22
Lipid metabolism during pregnancy: consequences for mother and child21
Exosomes and lipid metabolism in metabolic and cardiovascular disorders21
Implementation science and genetic testing for familial hypercholesterolemia21
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances20
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?19
Familial hypercholesterolemia in children and the importance of early treatment18
Editorial introductions17
Recent advances in understanding the spectrum of genetic determinants of lipoprotein(a) levels16
Nonalcoholic fatty liver disease: an update16
The current state of apolipoprotein E in dyslipidemia15
Genetic determinants of pancreatitis risk in hypertriglyceridemia15
A new SPRING in lipid metabolism15
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives14
The need for national and international registries of patients with elevated lipoprotein(a)14
Editorial introductions14
Familial hypercholesterolemia in pregnancy14
Genetic insights from Greenland: when geography, history and genomics converge14
APOE and familial hypercholesterolemia14
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets13
From clinical development to real-world outcomes with inclisiran13
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?13
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?13
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion13
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent12
Can small dense LDL cholesterol be estimated from the lipid profile?12
Evolving guidelines on lipoprotein(a)12
Editorial introductions11
In the wake of the Scandinavian Simvastatin Survival Study trial11
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis11
Distinct roles of size-defined HDL subpopulations in cardiovascular disease10
Cardiomyocytes, sphingolipids and cardio myotoxicity10
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis10
Pregnancy, cardiovascular health, and microchimerism10
Newborn screening for lipid disorders10
Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis9
Genetic testing for familial hypercholesterolemia9
Clinical associations between exercise and lipoproteins9
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review9
Strategies for management of patients with elevated lipoprotein(a)9
Altered cardiovascular risk pattern of LDL cholesterol in older adults9
0.068004131317139